Global Interventional Neurology Market To Showcase Energetic Demand During The Period Until 2026
Tissue plasminogen activators (tPAs) are used for treatment of
stroke, aneurysms, stenosis, and vascular malformations. A study
published in the New England Journal of Medicine stated that
Neurointerventional surgery in addition to IV-administered
"clot-busting" tissue plasminogen activator (IV-tPA)
therapy is more effective than administering IV-tPA alone for the
treatment of stroke.
According to the Brain Aneurysm Foundation (BAF), brain aneurysm
accounts for around 500,000 deaths each year. BAF estimates that
aneurysm is predominant in the age group of 35–60 years. Moreover,
globally around 15 million people suffer a stroke every year, as per
stats released by the World Heart Federation. High incidence of
stroke and brain aneurysm is contributing to increasing demand for
interventional neurology devices. Furthermore, introduction of new
techniques such as flow diverter and aspiration are propelling demand
for interventional neurology devices. The global Interventional
neurology market was valued at US$ 1,694.5 million in 2015 and is
expected to expand at a CAGR of 5.3% during the forecast period (2016
– 2024).
Market dynamics
Factors such as increasing prevalence of brain aneurysms, and
stroke, government programs to decrease the burden of traumatic brain
injury, technological advancements plugging treatment gaps and
availability of reimbursement are driving demand for
neurointerventional devices. However, high cost and negative
perception about neurointerventional devices is impacting the demand
negatively. Companies are therefore, adopting different strategies
such as providing FDA approved on-site training, strategic
collaborations, and technology upgrades in order to increase their
market presence and engage with customers.
Download the
PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/56
Market Taxonomy
This report segments the interventional neurology market on the
basis of product type, technique, therapeutic application and end
use. On the basis of product type the market has been segmented into
embolic coils, carotid stents, intracranial stents, neurovascular
thrombectomy devices, embolic protection devices, and flow diverter
devices. On the basis of technique, the market is segmented into
Neurothrombectomy Procedure, Cerebal Angiography Technique, Stenting
Technique, Coiling Procedure Technique, and Flow Disruption
Technique. The therapeutic application of interventional neurology
devices include brain aneurysm, ischemic strokes, artery stenosis,
vein stenosis and others. In terms of end use, the global
interventional neurology market is analyzed for hospitals and
ambulatory centers. The market is also analyzed across major
geographies namely North America, Europe, Asia Pacific, Latin
America, Middle East, and Africa.
Key features of the study:
-
This report provides in-depth analysis of neurointerventional devices and their usage preferences
-
This study provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year
-
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this industry
-
This study provides vital insights about market drivers, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the market players
-
The report takes into account these factors in addition to the critical limiting factors and evolving industry trends while analyzing the market value and growth (%) during the forecast period
Detailed Segmentation:
-
Global Interventional Neurology Market, By Product Type:
-
Embolic coils
-
Carotid stents
-
Intracranial stents
-
Neurovascular thrombectomy devices
-
Embolic protection devices
-
Flow diverter devices
-
Intravascular Devices
-
Liquid Embolic Devices
-
Balloons
-
Stent Retrievers
-
Market players need to address demand-shift in devices and
procedural techniques
The global Interventional neurology market is undergoing a
demand-shift in terms of products and techniques to treat stroke and
aneurysms. For instance, demand for bare platinum coils is growing at
a rapid pace as compared to that for coated coils. This is mainly due
to high costs of coated coils and their less improved clinical
outcomes compared to bare platinum coils. The highly touted
International Subarachnoid Aneurysm Trial (ISAT) demonstrated
improved clinical outcomes with coils rather than clipping, which
resulted in decline in the usage of clips in neurovascular surgery.
Strategic channel distribution agreements among
manufacturers to bolster their regional reach
Codman Neuro entered into agreement with InNeuroCo, Inc. for the
European distribution rights for intermediate catheters (ICs).
Similarly, Covidien (now Medtronic) entered into an exclusive
distribution agreement with Pulsar Vascular, Inc. to market and
promote PulseRider in Europe, the Middle East, and Africa. PulseRider
is a minimally invasive device intended for use (with embolic coils)
for treatment of unruptured wide-neck intracranial aneurysms. Such
strategic distribution partnership are helping market leaders to
expand their global footprint. Click To Read More On
Interventional
Neurology Market
Comments
Post a Comment